ARCHIVES

In Brief: Chabner Says He ”Has No Intention Of Leaving NCI; “Yarbro Named Clinical Indicators Chairman

This article is from The Cancer Letter archive.

Vol. 14 No. 36 | September 2, 1988

Download PDF Visit The Full Archive

Related Articles

NCI Awards $59M Contract For Key Project To consolidate Phase III Trial Administration

October 29, 1999

Phase III Xilonix Study Halted Following Unscheduled Analysis

September 26, 2014

In Surgery vs Radiotherapy, Outcome Differences Equalize After 15 Years Follow-up

February 22, 2013

In Brief: Stoval to Receive ACCC Award; Groopman, Sigal, Named to Board of Scientific Advisors

March 12, 1999

Cooperative Groups: Insurer To Cover Patient Care Costs In Clinical Trials

December 4, 1998

Studies Test New Agents Offering Relief From Treatment-Related Side Effects

July 30, 2004